IGC Pharma Granted European Patent Titled 'Cannabinoid Composition and Method for Treating'
Portfolio Pulse from Benzinga Newsdesk
IGC Pharma has been granted a European patent for a 'Cannabinoid Composition and Method for Treating'. This could potentially open up new markets and revenue streams for the company.

October 19, 2023 | 7:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
IGC Pharma's new European patent could potentially increase its market reach and revenue. This could have a positive impact on the company's stock in the short term.
Patents provide companies with exclusive rights to their inventions, preventing competitors from copying their products. This can lead to increased market share and revenue, which can positively impact a company's stock price. Given that this patent is for a 'Cannabinoid Composition and Method for Treating', it could potentially open up new markets for IGC Pharma, leading to increased revenue and a positive impact on its stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100